Peptide Lyophilisation:
From Formulation to
Stable Puck

Why Lyophilise Peptides?

Peptides in aqueous solution are inherently unstable. The very water that makes them soluble also drives their degradation. Hydrolysis — the water-mediated cleavage of peptide bonds — is the dominant chemical degradation pathway in solution. Oxidation of susceptible residues (methionine, cysteine, tryptophan, histidine) proceeds continuously in the presence of dissolved oxygen and moisture. Aggregation — where individual peptide molecules associate into non-native assemblies — is accelerated by both temperature and freeze-thaw cycles in solution.

Lyophilisation solves all three problems simultaneously by removing the solvent. Without bulk water, hydrolysis rates drop by several orders of magnitude. Without molecular mobility in an aqueous phase, aggregation is dramatically suppressed. In a correctly dried, sealed lyophilisate, many peptides are stable for two years or more at −20°C, and for weeks to months at room temperature — a storage flexibility that solution formulations cannot offer.

Pre-Formulation: What Goes Into the Vial

The composition of the solution entering the lyophiliser determines almost everything about the outcome: cake appearance, reconstitution time, peptide stability, and cycle efficiency. For a simple peptide formulation targeting research use, the ideal approach is to keep the excipient system as simple as possible — complexity in formulation introduces complexity in process development and failure mode analysis.

The Core Components of a Simple Peptide Lyophilisate

A minimal but robust peptide lyophilisation formulation requires four elements: the peptide itself, a bulking agent (mannitol is the subject of this review), a buffer to control pH, and sufficient water as the solvent to be removed. Some formulations add a lyoprotectant (trehalose or sucrose) for additional peptide protection, and a surfactant (polysorbate 80) for hydrophobic peptides prone to surface adsorption and aggregation. However, for many short research peptides at the milligram scale, mannitol alone as an excipient is often sufficient to produce an acceptable lyophilisate.

Solution Concentration Before Lyophilisation

Total solid content of the pre-lyophilisation solution (peptide plus all excipients) should typically fall in the range of 1–10% w/v. Solutions that are too dilute produce extremely fragile, low-mass cakes that are prone to mechanical disruption and poor reconstitution performance. Solutions that are too concentrated can lead to extended primary drying times, increased risk of collapse, and difficulties achieving low residual moisture in secondary drying.

For research peptides at typical fill volumes of 1–5 mL into 10 mL vials, a total solids concentration of 3–7% w/v is a practical working range that balances cycle efficiency with cake quality.

Mannitol as Bulking Agent: Ratios & Behaviour

Mannitol (D-mannitol, MW 182.2 g/mol) is the most widely used bulking agent in lyophilised injectable formulations. Approximately 37% of marketed lyophilised injectable products in the US and Europe contain mannitol as a sole excipient, at concentrations ranging from 0.04 to 5.5% w/v. Its physicochemical properties make it distinctly advantageous over alternatives such as glycine or lactose for peptide applications.

Why Mannitol Works

Mannitol crystallises readily during freezing when properly annealed. This crystallisation is the key functional property: the mannitol crystal lattice provides a rigid, self-supporting three-dimensional scaffold that maintains vial volume and pore structure through the primary drying phase. Without a crystallising bulking agent, the amorphous dried material often collapses or shrinks during primary drying, producing a dense cake with poor pore connectivity and slow, incomplete reconstitution.

Mannitol's Tg' (glass transition temperature of the maximally freeze-concentrated solution) is higher than that of most other polyols — typically reported at approximately −25°C to −28°C — which provides a wider operational window for primary drying without collapse.

The Mannitol-to-Peptide Mass Ratio

For simple peptide lyophilisation, the mannitol-to-peptide mass ratio is the single most important formulation parameter. Published literature and industrial practice converge on the following guidance:

Mannitol Phase Behaviour: The Hemihydrate Risk

A critical practical consideration is that mannitol can exist in several polymorphic forms and — importantly — as a metastable crystalline hemihydrate in the final lyophilisate. If annealing is insufficient or if the cycle is too aggressive, mannitol hemihydrate may persist in the cake. On storage, the hemihydrate can release water into the amorphous peptide phase, dramatically accelerating degradation. Proper annealing (see Section 4) and secondary drying (Section 7) mitigate this risk.

When to Add a Second Excipient

For hydrophobic, disulfide-containing, or aggregation-prone peptides, adding trehalose or sucrose at a mannitol:disaccharide ratio of approximately 3:1 w/w provides additional lyoprotection beyond what crystalline mannitol alone can offer. The disaccharide remains amorphous after lyophilisation and provides hydrogen-bonding stabilisation at the peptide surface. Wang et al. (2010) demonstrated that a 3:1 mannitol-to-trehalose system produced purity retention above 97% after 18 months at 5°C across 15 different peptide formulations — a robust validation of this binary approach for longer-term stability requirements.

The Freezing Step: Temperature, Rate & Annealing

Freezing is the most consequential and most underappreciated step in the lyophilisation process. The ice crystal structure formed during freezing directly determines the pore architecture of the dried cake — and therefore the reconstitution speed, the primary drying rate, and the uniformity of peptide distribution in the final product.

Freezing Temperature Target

The shelf temperature during freezing must be set sufficiently below the eutectic point of the formulation to ensure complete solidification of all components. For mannitol-based peptide formulations, the product temperature must reach at least −40°C to ensure complete freezing of the maximally freeze-concentrated solution. Shelf temperature is typically set to −45°C to −50°C to ensure product temperature reaches the required level, accounting for heat transfer resistance between shelf and vial bottom.

Cooling Rate

The shelf cooling rate during freezing is typically set between 0.5°C/min and 1.5°C/min for research peptide formulations. Faster cooling produces smaller, more uniform ice crystals and a more homogeneous pore structure — which tends to produce more uniform cakes across a batch. Slower cooling produces larger ice crystals and coarser pores — faster individual sublimation rates during primary drying, but more variable product between vials.

The Annealing Hold — Critical for Mannitol

Annealing is a hold step at a temperature above the Tg' of the formulation but below the melting point of ice — typically −15°C to −20°C for mannitol formulations. During annealing, ice crystals Ostwald-ripen (smaller crystals dissolve and redeposit onto larger ones), and — critically for mannitol — the bulking agent completes crystallisation. Without adequate annealing, mannitol may remain partially amorphous in the frozen state, leading to collapse during primary drying as the amorphous fraction softens.

Published guidance recommends an annealing hold of 1–3 hours at −15°C to −20°C for mannitol-containing formulations. This is a non-negotiable step for reliable, collapse-free lyophilisation of mannitol-based peptide formulations.

The Complete Freeze-Dry Cycle Profile

A lyophilisation cycle for a research peptide with mannitol excipient consists of four distinct phases: loading and equilibration, freezing (with annealing), primary drying, and secondary drying. Each phase has defined shelf temperature, chamber pressure, and time parameters that must be set appropriately for the formulation.

Primary Drying: The Physics of Sublimation

Primary drying is the sublimation phase — ice transforms directly from solid to vapour under reduced pressure, without passing through liquid. It is the longest phase of the cycle and the most technically demanding to optimise, because product temperature must be maintained below the collapse temperature (Tc) throughout.

The Collapse Temperature for Mannitol Formulations

Collapse is the loss of the porous cake structure due to viscous flow of the amorphous phase when product temperature exceeds Tc. For mannitol-based peptide formulations, Tc typically falls between −28°C and −35°C. Exceeding Tc during primary drying produces a glassy, shrunken, poorly porous cake — mechanically altered, slow to reconstitute, and potentially altered in peptide conformation.

The shelf temperature during primary drying is therefore typically set 3–5°C below the Tc, accounting for the temperature gradient between shelf and product. For most mannitol-peptide formulations, a shelf temperature of −25°C to −30°C at chamber pressures of 50–150 mTorr keeps the product temperature safely below Tc.

Chamber Pressure Selection

Chamber pressure during primary drying influences both the sublimation rate and the product temperature. Lower pressure increases sublimation rate but also lowers the heat transfer efficiency to the product. The optimal pressure for most peptide formulations lies between 50 and 150 mTorr — a range that balances sublimation rate against product temperature control.

Secondary Drying: Removing Bound Water

At the end of primary drying, the cake still contains 5–10% residual moisture as unfrozen, adsorbed water bound to the peptide and excipient surfaces. This bound water does not crystallise and cannot be removed by sublimation — it must be desorbed by raising the product temperature while maintaining the vacuum.

Temperature Ramp and Hold

Secondary drying begins with a controlled ramp of shelf temperature from the primary drying setpoint to between +25°C and +40°C. The ramp rate should be conservative — typically 0.1°C/min to 0.3°C/min — to avoid thermal stress to the peptide as the product passes through the glass transition temperature of the dried formulation. Too fast a ramp can cause local melting or structural disruption of the amorphous regions of the cake.

The upper temperature for secondary drying depends on the thermal stability of the peptide. For most short research peptides (under ~30 amino acids), +25°C to +30°C is used. For thermally stable peptides or when very low residual moisture is required, +40°C is achievable. The hold time at the final temperature is typically 6–12 hours for a 3–5 mL fill in a 10 mL vial.

Monitoring Drying Endpoint

The secondary drying endpoint is confirmed by residual moisture measurement (Karl Fischer titration is the reference method) or gravimetric analysis. Process analytical technology (PAT) approaches including mass spectrometry of the condenser off-gas are used in commercial settings but are less common in research-scale lyophilisers. For research applications, the practical approach is to run the secondary drying hold for at least 8–12 hours at the target temperature, then verify residual moisture on representative vials.

Puck Geometry: Why Shape and Size Matter

The physical geometry of the lyophilised cake — commonly called the "puck" in the industry — is not merely an aesthetic consideration. Puck dimensions directly determine reconstitution speed, the surface-area-to-volume ratio available for water penetration, and the mechanical integrity of the cake during shipping and handling.

What Determines Puck Geometry

Puck geometry is a product of three interacting variables: the fill volume in the vial, the vial internal diameter, and the total solids concentration of the pre-lyophilisation solution. The key derived parameter is fill depth — the height of liquid in the vial before lyophilisation. After drying, the cake height is approximately proportional to the total solids content of the original fill (since all water is removed).

Optimal Puck Dimensions for Research Peptides

For research peptides in standard 10 mL vials (internal diameter approximately 22 mm), the following fill volume guidance produces optimal puck geometry for reconstitution performance:

Residual Moisture: The Critical Quality Attribute

Residual moisture — the weight percentage of water remaining in the lyophilisate after the complete drying cycle — is the single most important quality attribute of a lyophilised peptide product. It is not merely a process metric: it is a direct predictor of long-term stability.

Target Moisture Content

The published pharmaceutical consensus is that a residual moisture content below 3% w/w is required for acceptable long-term peptide stability at refrigeration temperatures, and below 1–2% for products intended to be stored at room temperature or to have multi-year shelf lives. Values above 3% may result in acceptable short-term appearance but accelerated degradation over months.

Why Residual Moisture Drives Degradation

Even small amounts of residual water — 3–5% — dramatically increase molecular mobility in the solid matrix. Water acts as a plasticiser: it depresses the glass transition temperature (Tg) of the amorphous cake, softening the glassy matrix and allowing molecular motion. This mobility enables all the degradation reactions that lyophilisation is supposed to prevent: hydrolysis restarts, oxidation proceeds, and aggregation becomes possible again as molecules are no longer immobilised.

The relationship between residual moisture and stability is non-linear — stability degrades slowly above 3% and catastrophically above 5%. For quality-critical research peptides, residual moisture should always be verified by Karl Fischer titration on representative vials after cycle completion.

Measurement Methods

Peptide Stability in the Lyophilised State

A correctly lyophilised peptide is dramatically more stable than the same material in solution — but stability is not infinite, and it is not uniform across all peptide classes.

Primary Degradation Pathways in the Solid State

Even in a well-dried cake, several degradation processes can proceed slowly. Oxidation of methionine, cysteine, and tryptophan residues continues in the presence of residual oxygen in the headspace — mitigated by nitrogen or argon backfilling. Deamidation of asparagine and glutamine residues is slowed but not eliminated at low moisture. Diketopiperazine formation can occur at the N-terminus of peptides with adjacent amino acids under certain storage conditions. Racemisation of aspartate residues is a known risk for long-term storage.

Stability Data: Mannitol-Formulated Peptides

Wang et al. (2010) demonstrated that mannitol-trehalose (3:1) lyophilised peptide formulations retained greater than 97% purity after 18 months at 5°C across 15 different peptide sequences — representing the strongest published dataset for simple mannitol-based peptide lyophilisation. The CSP7 peptide formulation study (referenced in Influence of Processing Conditions, 2006) showed greater than 96% stability in mannitol-excipient lyophilisates for up to 10 months at 5°C and up to 4 weeks at room temperature.

Storage Conditions Summary

Reconstitution: Science and Best Practice

Reconstitution — dissolving the lyophilised cake back into aqueous solution — appears straightforward but is in fact a technically sensitive step that can introduce artefacts, losses, and degradation if performed incorrectly.

Reconstitution Vehicle Selection

The choice of reconstitution vehicle depends on the downstream application. Sterile water for injection (SWFI) is the most common choice when tonicity adjustment is to be made at the point of use. Bacteriostatic water (0.9% benzyl alcohol) is preferred for multi-dose formulations requiring antimicrobial preservation. Isotonic saline or phosphate-buffered saline are used when the downstream assay requires physiological conditions from the outset.

For hydrophobic peptides with poor aqueous solubility, initial reconstitution with a small volume of acetic acid (0.1–1% w/v) or acetonitrile/water mixtures may be required before dilution with aqueous buffer — always following the specific solubility guidance for the peptide in question.

Reconstitution Technique

Add the reconstitution liquid gently down the side of the vial, not directly onto the cake — direct impact can mechanically disaggregate the puck and cause foaming, which can shear-denature sensitive peptides. Swirl gently; do not vortex or shake vigorously. Allow sufficient time for complete dissolution — a well-lyophilised mannitol-peptide cake should dissolve in under 60 seconds with gentle swirling. Extended reconstitution times (>5 minutes) indicate poor cake quality, excessive fill depth, collapse, or high residual moisture.

Volume Reduction Factor

A powerful advantage of lyophilisation is the ability to reconstitute to a higher concentration than the original pre-lyophilisation solution. Patent literature (US7879805) describes reconstituting to concentrations 2–80× higher than the original, with 3–6× being the practical working range for most peptide formulations. For a peptide lyophilised from a 1 mg/mL solution in 5 mL fill volume (5 mg total), reconstituting into 0.5 mL produces a 10 mg/mL solution — a 10× concentration factor with no additional peptide synthesis.

Troubleshooting Common Lyophilisation Problems